8 Patents
- US125694862026Calmodulin Inhibitors, CHK2 Inhibitors and RSK Inhibitors for the Treatment of Ribosomal Disorders and Ribosomapathies
DANA-FARBER CANCER INSTITUTE, Inc.
0 cites - 0 cites
- 0 cites
- US120233852024Tunable Endogenous Protein Degradation with Heterobifunctional Compounds
DANA-FARBER CANCER INSTITUTE, Inc.
0 cites - US119446252024Calmodulin Inhibitors, Chk2 Inhibitors and RSK Inhibitors for the Treatment of Ribosomal Disorders and Ribosomapathies
DANA-FARBER CANCER INSTITUTE, Inc.
0 cites - 0 cites
- US115835862023Methods to Induce Targeted Protein Degradation Through Bifunctional Molecules
DANA-FARBER CANCER INSTITUTE, Inc.
0 cites - US115780752023Degradation of Protein Kinases by Conjugation of Protein Kinase Inhibitors with E3 Ligase Ligand and Methods of Use
Dana-farber Cancer Institute, Inc.
0 cites